[Federal Register Volume 86, Number 179 (Monday, September 20, 2021)]
[Rules and Regulations]
[Pages 52083-52088]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20251]



40 CFR Part 180

[EPA-HQ-OPP-2020-0227; FRL-8857-01-OCSPP]

Pyraclostrobin; Pesticide Tolerances

AGENCY: Environmental Protection Agency (EPA).

ACTION: Final rule.


SUMMARY: This regulation establishes tolerances for residues of 
pyraclostrobin in or on pomegranate. Interregional Research Project 
Number 4 (IR-4) requested these tolerances under the Federal Food, 
Drug, and Cosmetic Act (FFDCA).

DATES: This regulation is effective September 20, 2021. Objections and 
requests for hearings must be received on or before November 19, 2021, 
and must be filed in accordance with the instructions provided in 40 
CFR part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).

ADDRESSES: The docket for this action, identified by docket 
identification (ID) number EPA-HQ-OPP-2020-0227, is available at http://www.regulations.gov or at the Office of Pesticide Programs Regulatory 
Public Docket (OPP Docket) in the Environmental Protection Agency 
Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 
1301 Constitution Ave. NW, Washington, DC 20460-0001. The Public 
Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through 
Friday, excluding legal holidays. The telephone number for the Public 
Reading Room is (202) 566-1744, and the telephone number for the OPP 
Docket is (703) 305-5805.
    Due to the public health emergency, the EPA Docket Center (EPA/DC) 
and Reading Room was closed to public visitors on March 31, 2020. Our 
EPA/DC staff will continue to provide customer service via email, 
phone, and webform. For further information on EPA/DC services, docket 
contact information and the current status of the EPA/DC and

[[Page 52084]]

Reading Room, please visit http://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: Marietta Echeverria, Registration 
Division (7505P), Office of Pesticide Programs, Environmental 
Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-
0001; main telephone number: (703) 305-7090; email address: 
[email protected].


I. General Information

A. Does this action apply to me?

    You may be potentially affected by this action if you are an 
agricultural producer, food manufacturer, or pesticide manufacturer. 
The following list of North American Industrial Classification System 
(NAICS) codes is not intended to be exhaustive, but rather provides a 
guide to help readers determine whether this document applies to them. 
Potentially affected entities may include:
     Crop production (NAICS code 111).
     Animal production (NAICS code 112).
     Food manufacturing (NAICS code 311).
     Pesticide manufacturing (NAICS code 32532).

B. How can I get electronic access to other related information?

    You may access a frequently updated electronic version of EPA's 
tolerance regulations at 40 CFR part 180 through the Government 
Publishing Office's e-CFR site at http://www.ecfr.gov/cgi-bin/text-idx?&c=ecfr&tpl=/ecfrbrowse/Title40/40tab_02.tpl.

C. How can I file an objection or hearing request?

    Under FFDCA section 408(g), 21 U.S.C. 346a, any person may file an 
objection to any aspect of this regulation and may also request a 
hearing on those objections. You must file your objection or request a 
hearing on this regulation in accordance with the instructions provided 
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify 
docket ID number EPA-HQ-OPP-2020-0227 in the subject line on the first 
page of your submission. All objections and requests for a hearing must 
be in writing and must be received by the Hearing Clerk on or before 
November 19, 2021. Addresses for mail and hand delivery of objections 
and hearing requests are provided in 40 CFR 178.25(b).
    In addition to filing an objection or hearing request with the 
Hearing Clerk as described in 40 CFR part 178, please submit a copy of 
the filing (excluding any Confidential Business Information (CBI)) for 
inclusion in the public docket. Information not marked confidential 
pursuant to 40 CFR part 2 may be disclosed publicly by EPA without 
prior notice. Submit the non-CBI copy of your objection or hearing 
request, identified by docket ID number EPA-HQ-OPP-2020-0227, by one of 
the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the online instructions for submitting comments. Do not submit 
electronically any information you consider to be CBI or other 
information whose disclosure is restricted by statute.
     Mail: OPP Docket, Environmental Protection Agency Docket 
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW, Washington, DC 
     Hand Delivery: To make special arrangements for hand 
delivery or delivery of boxed information, please follow the 
instructions at http://www.epa.gov/dockets/contacts.html.
    Additional instructions on commenting or visiting the docket, along 
with more information about dockets generally, is available at http://www.epa.gov/dockets.

II. Summary of Petitioned-For Tolerance

    In the Federal Register of September 30, 2020 (85 FR 61681) (FRL-
10014-74), EPA issued a document pursuant to FFDCA section 408(d)(3), 
21 U.S.C. 346a(d)(3), announcing the filing of a pesticide petition (PP 
0E8826) by IR-4, IR-4 Project Headquarters, Rutgers, The State 
University of New Jersey, 500 College Road East, Suite 201W, Princeton, 
NJ 08540. The petition requested to establish tolerances in 40 CFR 
180.582 for residues of the sum of pyraclostrobin, (carbamic acid, [2-
methyl ester) and its desmethoxy metabolite (methyl-N-[[[1-(4-
chlorophenyl)-1H-pyrazol-3-yl]oxy]methyl] phenylcarbamate), calculated 
as the stoichiometric equivalent of pyraclostrobin, in or on the raw 
agricultural commodity pomegranate at 0.3 ppm. That document referenced 
a summary of the petition prepared by BASF, the registrant, which is 
available in the docket, http://www.regulations.gov. No comments were 
received in response to the notice of filing.

III. Aggregate Risk Assessment and Determination of Safety

    Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a 
tolerance (the legal limit for a pesticide chemical residue in or on a 
food) only if EPA determines that the tolerance is ``safe.'' Section 
408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a 
reasonable certainty that no harm will result from aggregate exposure 
to the pesticide chemical residue, including all anticipated dietary 
exposures and all other exposures for which there is reliable 
information.'' This includes exposure through drinking water and in 
residential settings but does not include occupational exposure. 
Section 408(b)(2)(C) of FFDCA requires EPA to give special 
consideration to exposure of infants and children to the pesticide 
chemical residue in establishing a tolerance and to ``ensure that there 
is a reasonable certainty that no harm will result to infants and 
children from aggregate exposure to the pesticide chemical residue. . . 
    Consistent with FFDCA section 408(b)(2)(D), and the factors 
specified in FFDCA section 408(b)(2)(D), EPA has reviewed the available 
scientific data and other relevant information in support of this 
action. EPA has sufficient data to assess the hazards of and to make a 
determination on aggregate exposure for pyraclostrobin including 
exposure resulting from the tolerances established by this action. 
EPA's assessment of exposures and risks associated with pyraclostrobin 

A. Toxicological Profile

    EPA has evaluated the available toxicity data and considered its 
validity, completeness, and reliability as well as the relationship of 
the results of the studies to human risk. EPA has also considered 
available information concerning the variability of the sensitivities 
of major identifiable subgroups of consumers, including infants and 
    The primary target tissues following repeated pyraclostrobin 
exposure appear to be mucosal membranes, with histopathology or 
secondary effects (e.g., diarrhea) observed in different species. The 
primary effects were decreased body weight and food consumption in 
addition to diarrhea. There was no observed neurotoxicity, 
mutagenicity, genotoxicity, or immunotoxicity in the database. Also, 
there was no evidence of increased susceptibility following pre-natal 
exposure to rats and rabbits in the developmental toxicity studies, nor 
following pre- and post-natal exposure to rats in the multi-generation 
reproduction study. Pyraclostrobin is classified as ``not likely to be 
carcinogenic to humans.''
    Additional information on the toxicological profile can be found at 
http://www.regulations.gov in the

[[Page 52085]]

document titled ``Pyraclostrobin; Human Health Risk Assessment for a 
New Use on Pomegranate'' (hereinafter ``Pyraclostrobin Human Health 
Risk Assessment'') in docket ID number EPA-HQ-OPP-2020-0227.

B. Toxicological Points of Departure/Levels of Concern

    Once a pesticide's toxicological profile is determined, EPA 
identifies toxicological points of departure (POD) and levels of 
concern to use in evaluating the risk posed by human exposure to the 
pesticide. For hazards that have a threshold below which there is no 
appreciable risk, the toxicological POD is used as the basis for 
derivation of reference values for risk assessment. PODs are developed 
based on a careful analysis of the doses in each toxicological study to 
determine the dose at which no adverse effects are observed (the NOAEL) 
and the lowest dose at which adverse effects of concern are identified 
(the LOAEL). Uncertainty/safety factors are used in conjunction with 
the POD to calculate a safe exposure level--generally referred to as a 
population-adjusted dose (PAD) or a reference dose (RfD)--and a safe 
margin of exposure (MOE). For non-threshold risks, the Agency assumes 
that any amount of exposure will lead to some degree of risk. Thus, the 
Agency estimates risk in terms of the probability of an occurrence of 
the adverse effect expected in a lifetime. For more information on the 
general principles EPA uses in risk characterization and a complete 
description of the risk assessment process, see http://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/assessing-human-health-risk-pesticide.
    A summary of the toxicological endpoints for pyraclostrobin used 
for human risk assessment can be found on pages 10-11 in the 
Pyraclostrobin Human Health Risk Assessment.

C. Exposure Assessment

    1. Dietary exposure from food and feed uses. In evaluating dietary 
exposure to pyraclostrobin, EPA considered exposure under the 
petitioned-for tolerances as well as all existing pyraclostrobin 
tolerances in 40 CFR 180.582. EPA assessed dietary exposures from 
pyraclostrobin in food as follows:
    i. Acute exposure. Quantitative acute dietary exposure and risk 
assessments are performed for a food-use pesticide if a toxicological 
study has indicated the possibility of an effect of concern occurring 
as a result of a 1-day or single exposure. Such effects were identified 
for pyraclostrobin.
    In conducting the acute dietary exposure assessment, EPA used the 
2003-2008 food consumption data from the U.S. Department of 
Agriculture's National Health and Nutrition Examination Survey, What We 
Eat in America (NHANES/WWEIA). A partially refined acute dietary 
exposure assessment was conducted for pyraclostrobin. The analysis used 
tolerance-level residues or highest average field trial residues (HAFT) 
and 100 percent crop treated (PCT).
    ii. Chronic exposure. In conducting the chronic dietary exposure 
assessment, EPA used the 2003-2008 food consumption data from the 
USDA's NHANES/WWEIA. A partially refined chronic dietary analysis was 
conducted for pyraclostrobin. The chronic dietary analysis included 
tolerance-level or average field trial residues and average PCT 
estimates when available.
    iii. Cancer. Pyraclostrobin is classified as ``Not Likely to Be 
Carcinogenic to Humans'' therefore, a cancer assessment is not needed.
    iv. Anticipated residue and PCT information. Section 408(b)(2)(F) 
of FFDCA states that the Agency may use data on the actual percent of 
food treated for assessing chronic dietary risk only if:
     Condition a: The data used are reliable and provide a 
valid basis to show what percentage of the food derived from such crop 
is likely to contain the pesticide residue.
     Condition b: The exposure estimate does not underestimate 
exposure for any significant subpopulation group.
     Condition c: Data are available on pesticide use and food 
consumption in a particular area, and the exposure estimate does not 
understate exposure for the population in such area.
    In addition, the Agency must provide for periodic evaluation of any 
estimates used. To provide for the periodic evaluation of the estimate 
of PCT as required by FFDCA section 408(b)(2)(F), EPA may require 
registrants to submit data on PCT.
    The following average PCT estimates were used in the chronic 
dietary risk assessments for the crops that are currently registered 
for pyraclostrobin: Almonds 45%; apples 20%; apricots 30%; barley 10%; 
green beans 5%; blueberries 40%; broccoli 5%; Brussels sprouts 15%; 
cabbage 10%; caneberries 50%; cantaloupes 15%; carrots 35%; cauliflower 
5%; celery 2.5%; cherries 55%; chicory 5%; corn 10%; cotton (seed 
treatment) 10%; cucumber 5%; dry beans/peas 10%; garlic 10%; grapefruit 
35%; grapes 30%; hazelnuts 20%; lemons 5%; lettuce 5%; nectarines 15%; 
oats 5%; onions 30%; oranges 5%; peaches 25%; peanuts 20%; pears 20%; 
green peas 5%; pecans 5%; peppers 15%; pistachios 30%; potatoes 20%; 
pumpkins 15%; soybeans (seed treatment) 10%; spinach 5%; squash 15%; 
strawberries 65%; sugar beets 50%; sugarcane 5%; sweet corn 5%; 
tangerines 10%; tomatoes 25%; walnuts 10%; watermelons 25%; wheat 5%.
    In most cases, EPA uses available data from United States 
Department of Agriculture/National Agricultural Statistics Service 
(USDA/NASS), proprietary market surveys, and California Department of 
Pesticide Regulation (CalDPR) Pesticide Use Reporting (PUR) for the 
chemical/crop combination for the most recent 10 years. EPA uses an 
average PCT for chronic dietary risk analysis and a maximum PCT for 
acute dietary risk analysis. The average PCT figure for each existing 
use is derived by combining available public and private market survey 
data for that use, averaging across all observations, and rounding to 
the nearest 5%, except for those situations in which the average PCT is 
less than 1% or less than 2.5%. In those cases, the Agency would use 
less than 1% or less than 2.5% as the average PCT value, respectively. 
The maximum PCT figure is the highest observed maximum value reported 
within the most recent 10 years of available public and private market 
survey data for the existing use and rounded up to the nearest multiple 
of 5%, except where the maximum PCT is less than 2.5%, in which case 
the Agency uses less than 2.5% as the maximum PCT.
    The Agency believes that the three conditions discussed in Unit 
III.C.1.iv. have been met. With respect to Condition a, PCT estimates 
are derived from Federal and private market survey data, which are 
reliable and have a valid basis. The Agency is reasonably certain that 
the percentage of the food treated is not likely to be an 
underestimation. As to Conditions b and c, regional consumption 
information and consumption information for significant subpopulations 
is taken into account through EPA's computer-based model for evaluating 
the exposure of significant subpopulations including several regional 
groups. Use of this consumption information in EPA's risk assessment 
process ensures that EPA's exposure estimate does not understate 
exposure for any significant subpopulation group and allows the Agency 
to be reasonably certain that no regional population is exposed to 
residue levels higher than those estimated by the Agency. Other than 
the data available through national food

[[Page 52086]]

consumption surveys, EPA does not have available reliable information 
on the regional consumption of food to which pyraclostrobin may be 
applied in a particular area.
    2. Dietary exposure from drinking water. The Agency used screening 
level water exposure models in the dietary exposure analysis and risk 
assessment for pyraclostrobin in drinking water. Further information 
regarding EPA drinking water models used in pesticide exposure 
assessment can be found at http://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/about-water-exposure-models-used-pesticide.
    Based on the Pesticide in Water Calculator (PWC), for the acute 
dietary risk assessment, EPA used an estimated drinking water 
concentration (EDWC) of 22 ppb into the DEEM-FCID Model. For the 
chronic exposure assessment, EPA used a value of 0.99 ppb.
    3. Non-dietary exposure. The term ``residential exposure'' is used 
in this document to refer to non-occupational, non-dietary exposure 
(e.g., for lawn and garden pest control, indoor pest control, 
termiticides, and flea and tick control on pets).
    Pyraclostrobin is currently registered for uses that may result in 
residential handler and post-application exposures, including 
commercial and residential use on lawns, as well as commercial use on 
ornamental turf and trees, golf courses, and parks.
    Based upon the hazard analysis for pyraclostrobin, short-term 
residential exposure that is available to be aggregated include 
incidental oral exposure (e.g., hand-to-mouth or object-to-mouth). 
Hand-to-mouth and object-to-mouth scenarios are considered inter-
related, and it is likely that they occur interspersed amongst each 
other across time; combining these scenarios would be overly 
conservative. Residential short and intermediate-term dermal exposures 
(from children, youth, or adult scenarios) are not being combined with 
incidental oral exposure due to differing endpoints selected. Based 
upon the available scenarios, incidental oral (hand-to-mouth) exposures 
were used in the pyraclostrobin short-term aggregate assessment.
    Further information regarding EPA standard assumptions and generic 
inputs for residential exposures may be found at http://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/standard-operating-procedures-residential-pesticide.
    4. Cumulative effects from substances with a common mechanism of 
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when 
considering whether to establish, modify, or revoke a tolerance, the 
Agency consider ``available information'' concerning the cumulative 
effects of a particular pesticide's residues and ``other substances 
that have a common mechanism of toxicity.''
    Unlike other pesticides for which EPA has followed a cumulative 
risk approach based on a common mechanism of toxicity, EPA has not made 
a common mechanism of toxicity finding as to pyraclostrobin and any 
other substances and pyraclostrobin does not appear to produce a toxic 
metabolite produced by other substances. For the purposes of this 
tolerance action, therefore, EPA has not assumed that pyraclostrobin 
has a common mechanism of toxicity with other substances.

D. Safety Factor for Infants and Children

    1. In general. Section 408(b)(2)(C) of FFDCA provides that EPA 
shall apply an additional tenfold (10X) margin of safety for infants 
and children in the case of threshold effects to account for prenatal 
and postnatal toxicity and the completeness of the database on toxicity 
and exposure unless EPA determines based on reliable data that a 
different margin of safety will be safe for infants and children. This 
additional margin of safety is commonly referred to as the FQPA Safety 
Factor (SF). In applying this provision, EPA either retains the default 
value of 10X, or uses a different additional safety factor when 
reliable data available to EPA support the choice of a different 
    2. Prenatal and postnatal sensitivity. In the rat developmental 
toxicity study, skeletal variations occurred at doses greater than or 
equal to those doses causing maternal toxicity (i.e., diarrhea, 
decreased body weight, food consumption, and clinical signs of 
toxicity). In the rabbit developmental study, increased resorptions per 
litter, increased post-implantation loss, and dams with total 
resorptions were observed. Since the cause of fetal death is 
undetermined and may be attributed to either maternal or direct embryo 
fetal toxicity, the effect is part of both the maternal and 
developmental LOAEL. In one rat reproduction study, systemic toxicity 
manifested as decreased body weights in both the parents and offspring, 
with offspring effects occurring at a higher dose level than parental 
toxicity. In the second rat reproduction study, no toxicity was 
observed in both parents and offspring. Therefore, there was no 
evidence of increased susceptibility (quantitatively) following pre-
natal exposure to rats and rabbits in the developmental studies nor 
following pre- and post-natal exposure to rats in the multi-generation 
reproduction studies.
    3. Conclusion. EPA has determined that reliable data show the 
safety of infants and children would be adequately protected if the 
FQPA SF were reduced to 1X. That decision is based on the following 

    i. The toxicity database for pyraclostrobin is complete.
    ii. There are no indications in any of the studies available 
that the nervous system is a target for pyraclostrobin. In the 
absence of definitive neurotoxicity or neuropathology findings in 
the neurotoxicity battery or elsewhere in the database, a 
developmental neurotoxicity study is not required.
    iii. For the reasons summarized in section III.D.2, the degree 
of concern for prenatal and postnatal toxicity is low.
    iv. There are no residual uncertainties identified in the 
exposure databases. The acute dietary exposure assessments were 
performed assuming 100 percent of the crops were treated with 
pyraclostrobin and incorporating tolerance-level or highest field 
trial residues. The chronic dietary exposure assessments were 
performed using average PCT estimates and tolerance-level or average 
field trial residues for crops in the screening level use analysis 
(SLUA), while 100 PCT was used for crops not included in the SLUA. 
EPA made conservative (protective) assumptions in the ground and 
surface water modeling used to assess exposure to pyraclostrobin in 
drinking water. Although the acute and chronic assessments included 
minor refinements, the use of field trial and PCT estimates ensures 
that actual exposures/risks from residues in food will not be 
underestimated. Although some of the residue values used in the 
dietary exposure assessment were refined, these assessments will not 
underestimate the dietary exposure to pyraclostrobin.

E. Aggregate Risks and Determination of Safety

    EPA determines whether acute and chronic dietary pesticide 
exposures are safe by comparing aggregate exposure estimates to the 
acute PAD (aPAD) and chronic PAD (cPAD). For linear cancer risks, EPA 
calculates the lifetime probability of acquiring cancer given the 
estimated aggregate exposure. Short-, intermediate-, and chronic-term 
risks are evaluated by comparing the estimated aggregate food, water, 
and residential exposure to the appropriate PODs to ensure that an 
adequate MOE exists.
    1. Acute risk. An acute aggregate risk assessment takes into 
account acute exposure estimates from dietary consumption of food and 
drinking water. Using the exposure assumptions described in this unit 
for acute exposure, EPA has concluded that acute exposure to 
pyraclostrobin from food and water will utilize 86% of the aPAD for 
females 13 to 49 years old, the only

[[Page 52087]]

population group of concern because no appropriate toxicological effect 
attributable to a single dose was observed for the general US 
population or any other population subgroup.
    2. Chronic risk. Using the exposure assumptions described in this 
unit for chronic exposure, EPA has concluded that chronic exposure to 
pyraclostrobin from food and water will utilize 28% of the cPAD for all 
children 1 to 2 years old, the population group receiving the greatest 
exposure. Chronic residential exposure to residues of pyraclostrobin is 
not expected.
    3. Short-term risk. Short-term aggregate exposure takes into 
account short-term residential exposure plus chronic exposure to food 
and water (considered to be a background exposure level).
    Pyraclostrobin is currently registered for uses that could result 
in short-term residential exposure, and the Agency has determined that 
it is appropriate to aggregate chronic exposure through food and water 
with short-term residential exposures to pyraclostrobin.
    Using the exposure assumptions described in this unit for short-
term exposures, EPA has concluded the combined short-term food, water, 
and residential exposures result in an aggregate MOE of 430 for 
children 1 to 2 years old. Because EPA's level of concern for 
pyraclostrobin is a MOE of 100 or below, this MOE is not of concern.
    4. Intermediate-term risk. Intermediate-term aggregate exposure 
takes into account intermediate-term residential exposure plus chronic 
exposure to food and water (considered to be a background exposure 
    A separate intermediate-term adverse effect was identified for 
pyraclostrobin. However, pyraclostrobin is not registered for any use 
patterns that would result in intermediate-term residential exposures 
that can be combined with background dietary exposures. Because there 
is no intermediate-term residential aggregate exposures and chronic 
dietary exposure has already been assessed under the appropriately 
protective cPAD, no further assessment of intermediate-term risk is 
necessary, and EPA relies on the chronic dietary risk assessment for 
evaluating intermediate-term risk for pyraclostrobin.
    5. Aggregate cancer risk for U.S. population. Pyraclostrobin is 
classified as ``Not Likely to Be Carcinogenic to Humans''; therefore, 
EPA does not expect pyraclostrobin exposures to pose an aggregate 
cancer risk.
    6. Determination of safety. Based on these risk assessments, EPA 
concludes that there is a reasonable certainty that no harm will result 
to the general population, or to infants and children from aggregate 
exposure to pyraclostrobin residues.

IV. Other Considerations

A. Analytical Enforcement Methodology

    Two adequate methods are available for enforcement purposes for 
residues of pyraclostrobin and its metabolites in/on plant commodities: 
a liquid chromatography with tandem mass spectroscopy (LC/MS/MS) method 
(BASF Method D9908) and a high-performance liquid chromatography/
ultraviolet (HPLC/UV) method (Method D9904).

B. International Residue Limits

    In making its tolerance decisions, EPA seeks to harmonize U.S. 
tolerances with international standards whenever possible, consistent 
with U.S. food safety standards and agricultural practices. EPA 
considers the international maximum residue limits (MRLs) established 
by the Codex Alimentarius Commission (Codex), as required by FFDCA 
section 408(b)(4).
    There is no Codex MRL for pyraclostrobin in or on pomegranate.

V. Conclusion

    Therefore, a tolerance is established for residues of 
pyraclostrobin in or on pomegranate at 0.3 ppm. Additionally, the 
Agency is putting back a footnote that states ``There is no U.S. 
registration on coffee, bean, green as of September 30, 2009'' to the 
table in paragraph (a)(1) that was inadvertently removed in 2013.

VI. Statutory and Executive Order Reviews

    This action establishes a tolerance under FFDCA section 408(d) in 
response to a petition submitted to the Agency. The Office of 
Management and Budget (OMB) has exempted these types of actions from 
review under Executive Order 12866, entitled ``Regulatory Planning and 
Review'' (58 FR 51735, October 4, 1993). Because this action has been 
exempted from review under Executive Order 12866, this action is not 
subject to Executive Order 13211, entitled ``Actions Concerning 
Regulations That Significantly Affect Energy Supply, Distribution, or 
Use'' (66 FR 28355, May 22, 2001) or Executive Order 13045, entitled 
``Protection of Children from Environmental Health Risks and Safety 
Risks'' (62 FR 19885, April 23, 1997). This action does not contain any 
information collections subject to OMB approval under the Paperwork 
Reduction Act (PRA) (44 U.S.C. 3501 et seq.), nor does it require any 
special considerations under Executive Order 12898, entitled ``Federal 
Actions to Address Environmental Justice in Minority Populations and 
Low-Income Populations'' (59 FR 7629, February 16, 1994).
    Since tolerances and exemptions that are established on the basis 
of a petition under FFDCA section 408(d), such as the tolerance in this 
final rule, do not require the issuance of a proposed rule, the 
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et 
seq.), do not apply.
    This action directly regulates growers, food processors, food 
handlers, and food retailers, not States or tribes, nor does this 
action alter the relationships or distribution of power and 
responsibilities established by Congress in the preemption provisions 
of FFDCA section 408(n)(4). As such, the Agency has determined that 
this action will not have a substantial direct effect on States or 
Tribal Governments, on the relationship between the National Government 
and the States or Tribal Governments, or on the distribution of power 
and responsibilities among the various levels of government or between 
the Federal Government and Indian Tribes. Thus, the Agency has 
determined that Executive Order 13132, entitled ``Federalism'' (64 FR 
43255, August 10, 1999) and Executive Order 13175, entitled 
``Consultation and Coordination with Indian Tribal Governments'' (65 FR 
67249, November 9, 2000) do not apply to this action. In addition, this 
action does not impose any enforceable duty or contain any unfunded 
mandate as described under Title II of the Unfunded Mandates Reform Act 
(UMRA) (2 U.S.C. 1501 et seq.).
    This action does not involve any technical standards that would 
require Agency consideration of voluntary consensus standards pursuant 
to section 12(d) of the National Technology Transfer and Advancement 
Act (NTTAA) (15 U.S.C. 272 note).

VII. Congressional Review Act (CRA)

    Pursuant to the CRA (5 U.S.C. 801 et seq.), EPA will submit a 
report containing this rule and other required information to the U.S. 
Senate, the U.S. House of Representatives, and the Comptroller General 
of the United States prior to publication of the rule in the Federal 
Register. This action is not a ``major rule'' as defined by 5 U.S.C. 

List of Subjects in 40 CFR Part 180

    Environmental protection, Administrative practice and procedure,

[[Page 52088]]

Agricultural commodities, Pesticides and pests, Reporting and 
recordkeeping requirements.

    Dated: September 13, 2021.
Marietta Echeverria,
Acting Director, Registration Division, Office of Pesticide Programs.

    Therefore, for the reasons stated in the preamble, EPA is amending 
40 CFR chapter I as follows:


1. The authority citation for part 180 continues to read as follows:

    Authority:  21 U.S.C. 321(q), 346a and 371.

2. In Sec.  180.582, amend the table in paragraph (a)(1) by adding in 
alphabetical order the commodity ``Pomegranate'' and a footnote 1 at 
the end of the table to read as follows:

Sec.  180.582  Pyraclostrobin; tolerances for residues.

    (a) * * *
    (1) * * *

                                                              Parts per
                         Commodity                             million
                                * * * * *
Pomegranate................................................         0.3
                               * * * * *
\1\ There is no U.S. registration on coffee, bean, green as of September
  30, 2009.

* * * * *
[FR Doc. 2021-20251 Filed 9-17-21; 8:45 am]